ID   ULUNDi001-A
SY   CSC-40F; CSC-40
DR   hPSCreg; ULUNDi001-A
DR   Wikidata; Q54990744
RX   PubMed=29331938;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Homozygous for PINK1 p.Gln456Ter (c.1366C>T) (ClinVar=VCV000002415) (PubMed=29331938).
CC   Derived from sampling site: Skin; dermis.
ST   Source(s): PubMed=29331938
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D21S11: 31.2,32.2
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C26845; Parkinson's disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-07-20; Version: 4
RX   PubMed=29331938; DOI=10.1016/j.scr.2018.01.001;
RA   Russ K., Marote A., Savchenko E., Collin A., Goldwurm S.,
RA   Pomeshchik Y., Roybon L.;
RT   "Generation of a human induced pluripotent stem cell line (CSC-40)
RT   from a Parkinson's disease patient with a PINK1 p.Q456X mutation.";
RL   Stem Cell Res. 27:61-64(2018).